IURII BUKHTA On Wednesday, cannabis investors reacted with glee after reading a scoop from Axios that the Trump administration was preparing to issue an order moving marijuana from a Schedule I to a Schedule III drug under the Controlled Substances Act. Multi-state operators surged on the news. After the development became official Thursday morning with a final order issued by the Justice Departme...
IURII BUKHTA On Wednesday, cannabis investors reacted with glee after reading a scoop from Axios that the Trump administration was preparing to issue an order moving marijuana from a Schedule I to a Schedule III drug under the Controlled Substances Act. Multi-state operators surged on the news. After the development became official Thursday morning with a final order issued by the Justice Department, MSOs gave up much of those gains. Why? A likely reason was a lack of clarity between Wednesday's report and the details in the DOJ's order. A department news release states that a hearing will be held on June 29 to discuss a “broader rescheduling” to Schedule III. Wednesday's action is actually quite narrow, only impacting marijuana for medical uses. And while Cheech and Chong's favorite vice may eventually become legalized federally, the truth is that if that happens, it could take many months if not years. What follows is a Seeking Alpha primer on what Schedule III reclassification does and doesn't do. No Federal Legalization Civil and criminal penalties remain for marijuana possession and distribution on the federal level. However, given cannabis is now a Schedule III drug, those punishments will likely become less harsh than when weed was a Schedule I substance. Currently, marijuana is legal for medical use in 40 states and recreational use in 24. Dispensaries operate legally in accordance with state laws in those jurisdictions. For the most part, the feds have steered clear of enforcement against these businesses and customers, instead focusing on illegal marijuana dealers and those with large possession of it. Cash Only For the foreseeable future, customers in states with legalization on the books won't see much difference in their transactions. They will still only be able to pay via cash. No credit cards, as US banks could face sanctions by accepting payments for a product considered illegal by federal law. Legislation to amend this has been introduced many time...
Goldman Sachs' Co-Head of Banking and Markets Ashok Varadhan said dealmaking remains resilient despite geopolitical tensions, pointing to an active pipeline including data center financing. He also struck a measured tone on markets, noting that periods of volatility are part of the cycle. Varadhan spoke in a wide-ranging interview at the Bloomberg Markets and Banking Summit in New York on April 22...
Goldman Sachs' Co-Head of Banking and Markets Ashok Varadhan said dealmaking remains resilient despite geopolitical tensions, pointing to an active pipeline including data center financing. He also struck a measured tone on markets, noting that periods of volatility are part of the cycle. Varadhan spoke in a wide-ranging interview at the Bloomberg Markets and Banking Summit in New York on April 22nd, 2026. (Source: Bloomberg)
Shares of SanDisk (NASDAQ:SNDK) are trading near $930 in Thursday’s session, down roughly 5% on the day. The pullback cools an extraordinary 295% year-to-date (YTD) rally that has made SNDK one of the hottest AI-exposed names in the technology sector. The current SNDK share price sits almost directly on top of the $928 analyst consensus ... SanDisk Climbs 295% YTD as AI Fuels Memory Mania: Can Q1 ...
Shares of SanDisk (NASDAQ:SNDK) are trading near $930 in Thursday’s session, down roughly 5% on the day. The pullback cools an extraordinary 295% year-to-date (YTD) rally that has made SNDK one of the hottest AI-exposed names in the technology sector. The current SNDK share price sits almost directly on top of the $928 analyst consensus ... SanDisk Climbs 295% YTD as AI Fuels Memory Mania: Can Q1 Results Justify the Run?
Meta (META) confirmed it will be cutting 10% of its workforce — about 8,000 employees. Yahoo Finance Tech Editor Dan Howley explains what we know so far.
Meta (META) confirmed it will be cutting 10% of its workforce — about 8,000 employees. Yahoo Finance Tech Editor Dan Howley explains what we know so far.
"Bloomberg Markets" follows the market moves across every global asset class and discusses the biggest issues for Wall Street. Today's guests: RBC Global Asset Management Head of Bluebay US Fixed Income Andrzej Skiba, Bloomberg's Ryan Vlastelica, Jacob Lorinc, Saleha Mohsin, George Ferguson, and Brian Platt. (Source: Bloomberg)
"Bloomberg Markets" follows the market moves across every global asset class and discusses the biggest issues for Wall Street. Today's guests: RBC Global Asset Management Head of Bluebay US Fixed Income Andrzej Skiba, Bloomberg's Ryan Vlastelica, Jacob Lorinc, Saleha Mohsin, George Ferguson, and Brian Platt. (Source: Bloomberg)
In this article REGN Follow your favorite stocks CREATE FREE ACCOUNT U.S. President Donald Trump (C) speaks during an event on advancing health care affordability in the Oval Office of the White House on April 23, 2026 in Washington, DC. Alex Wong | Getty Images Regeneron agreed to lower U.S. drug prices for some Americans as part of a deal with President Donald Trump, the White House said on Thur...
In this article REGN Follow your favorite stocks CREATE FREE ACCOUNT U.S. President Donald Trump (C) speaks during an event on advancing health care affordability in the Oval Office of the White House on April 23, 2026 in Washington, DC. Alex Wong | Getty Images Regeneron agreed to lower U.S. drug prices for some Americans as part of a deal with President Donald Trump, the White House said on Thursday. The biotech company will also offer the first hearing-loss gene therapy for free to eligible U.S. patients following regulatory approval of the product earlier Thursday. Regeneron is the latest in a string of major drugmakers to make pricing concessions for new and existing medicines under agreements with Trump. Those deals are part of his "most favored nation" effort to tie U.S. drug prices to the lowest ones in other developed nations. The agreements also exempt the companies from tariffs for three years, including Trump's planned up to 100% levies on some pharmaceutical products. The Trump administration has so far inked 17 deals, but is negotiating more with other biotech and pharma companies, said CMS deputy administrator Chris Klomp during a White House event on Thursday. Regeneron's deal comes just hours after the Food and Drug Administration approved the company's gene therapy, Otarmeni, which restored hearing in a small number of deaf children. The treatment received an expedited approval under the FDA's so-called National Priority Voucher program. The drug targets an ultra-rare genetic condition caused by a mutation that prevents the body from making a protein required for hearing. It's a significant breakthrough for a subset of patients who have long depended on cochlear implants. In a March note, Piper Sandler analysts estimated that the gene therapy will rake in peak sales of $130 million. -- CNBC's Angelica Peebles contributed to this report. Choose CNBC as your preferred source on Google and never miss a moment from the most trusted name in business new...
Force says it is ‘confident there was no offence’ and condemns ‘shameful’ behaviour by protesters The investigation into reports of a rape outside a church in Epsom that led to widespread public disorder will close as police are “confident there was no offence”. Surrey police received a report on Saturday 11 April that a woman had been raped near a church in the early hours of the morning after le...
Force says it is ‘confident there was no offence’ and condemns ‘shameful’ behaviour by protesters The investigation into reports of a rape outside a church in Epsom that led to widespread public disorder will close as police are “confident there was no offence”. Surrey police received a report on Saturday 11 April that a woman had been raped near a church in the early hours of the morning after leaving Labyrinth nightclub in Epsom. Continue reading...
Earnings Call Insights: AZZ Inc. (AZZ) Q4 fiscal 2026 Management View “We delivered a strong close to the year and achieved record sales and profitability for the third consecutive year.” (President, CEO & Director Thomas Ferguson) “Full year sales totaled $1.65 billion. Adjusted EBITDA surpassed $367 million and adjusted earnings per share grew 19% year-over-year to $6.19.” (President, CEO & Dire...
Earnings Call Insights: AZZ Inc. (AZZ) Q4 fiscal 2026 Management View “We delivered a strong close to the year and achieved record sales and profitability for the third consecutive year.” (President, CEO & Director Thomas Ferguson) “Full year sales totaled $1.65 billion. Adjusted EBITDA surpassed $367 million and adjusted earnings per share grew 19% year-over-year to $6.19.” (President, CEO & Director Ferguson) “A key milestone was the completion of our greenfield Precoat Metals facility in Washington, Missouri.” (President, CEO & Director Ferguson) “We further expanded our Metal Coatings platform last year through the acquisition of a galvanizing facility in Canton, Ohio.” (President, CEO & Director Ferguson) “In fiscal 2026, which ended February 28, 2026, we reported record sales of $1.65 billion, up 4.6% from the prior year.” (Chief Financial Officer Jason Crawford) “We reported record fourth quarter sales of $385.1 million, representing a 9.4% increase from $351.9 million in the prior year period.” (Chief Financial Officer Crawford) “Looking forward, industry research characterizes the AI data center build-out as more structural rather than cyclical and the U.S. data center electricity demand is expected to roughly double by the end of the decade.” (Chief Marketing, Communications & Investor Relations Officer David Nark) Outlook “So today, we are reiterating our fiscal 2027 guidance. Sales are expected to be in the range of $1.725 billion to $1.775 billion, adjusted EBITDA in the range of $360 million to $400 million and adjusted diluted earnings per share in the range of $6.50 to $7.” (President, CEO & Director Ferguson) “We estimate debt reduction to range from $130 million to $170 million in fiscal 2027.” (President, CEO & Director Ferguson) “Due to our strong balance sheet and desire to provide above-market growth, we will remain selectively aggressive in our approach to M&A opportunities.” (President, CEO & Director Ferguson) Compared with the prior quarter...
Four seats are put on sale for $2,299,998.85 each Fifa doesn’t set offerings, but some go above $100,000 Governing body takes 15% from both buyer and seller Fifa’s resale site has four tickets on sale for the World Cup final for just under $2.3m each. The $2,299,998.85 seats for the 19 July 19 at MetLife Stadium in East Rutherford, New Jersey, are located behind a goal in the lower deck in block 1...
Four seats are put on sale for $2,299,998.85 each Fifa doesn’t set offerings, but some go above $100,000 Governing body takes 15% from both buyer and seller Fifa’s resale site has four tickets on sale for the World Cup final for just under $2.3m each. The $2,299,998.85 seats for the 19 July 19 at MetLife Stadium in East Rutherford, New Jersey, are located behind a goal in the lower deck in block 124, row 45, seats 33-36. Continue reading...
Warren Buffett is known for his investing wisdom and for many wins during his legendary career. But he's also willing to admit he's prone to making mistakes, just like any other investor. One of the mistakes seems to have been investing in Kraft Heinz (NASDAQ: KHC) , with its stock price languishing over the last several years. In a 2019 interview, Buffett admitted that Berkshire Hathaway (which h...
Warren Buffett is known for his investing wisdom and for many wins during his legendary career. But he's also willing to admit he's prone to making mistakes, just like any other investor. One of the mistakes seems to have been investing in Kraft Heinz (NASDAQ: KHC) , with its stock price languishing over the last several years. In a 2019 interview, Buffett admitted that Berkshire Hathaway (which he was CEO of at the time) "overpaid" for large purchases of the stock. Buffett's successor as CEO directed Berkshire to sell its holdings in Kraft Heinz in January 2026. However, that sale did not finalize. While the food and beverage manufacturer has a difficult turnaround ahead, it seems that, in the short term at least, Kraft Heinz has a supporter other than Buffett. Continue reading
JHVEPhoto Warner Bros. Discovery ( WBD ) edged lower by 1.4% at least partly after some comments from California Attorney General Rob Bonta, who is probing the $110 billion deal with Paramount Skydance ( PSKY ). "We are looking, and there are red flags everywhere," Bonta said in an interview with Scott Macfarlane that was made on Wednesday and circulating around on Thursday. "We still have time if...
JHVEPhoto Warner Bros. Discovery ( WBD ) edged lower by 1.4% at least partly after some comments from California Attorney General Rob Bonta, who is probing the $110 billion deal with Paramount Skydance ( PSKY ). "We are looking, and there are red flags everywhere," Bonta said in an interview with Scott Macfarlane that was made on Wednesday and circulating around on Thursday. "We still have time if that's what we decide. But we are in the investigation phase. So we haven't decided yet our formal position." Bonta said the combination of the Hollywood heavyweights could impact prices going higher, choice/quality, competition, impact on the labor market, and wages going down."We see indications that all those things will happen," Bonta said. "That prices will go up for consumers, that wages will go down for workers." Bonta's comment come as Warner Bros. Discovery ( WBD ) shareholders approved the merger with Paramount Skydance ( PSKY ) at the special stockholders meeting Thursday morning. Senator Elizabeth Warren (D-Mass) reiterated her opposition to the Warner/Paramount deal in a posting on X on Thursday. "The Paramount-Warner Bros. merger isn't a done deal," Warren posted. "State attorneys general across the country are stepping up to stop this antitrust disaster. We need to keep up this fight." More on Warner Bros. Discovery, Paramount Skydance Corporation Paramount Skydance: A Debt-Heavy, Risky, Long-Term Stock Debt Will Eat Paramount's Future Returns Warner Bros. Discovery And Paramount Skydance: A Lower-Risk Arb Play And A Leveraged Bet Warner Bros. Discovery shareholders approve Paramount Skydance merger ‘Super Mario Galaxy Movie’ stays No. 1 as domestic box office slips 34%
Earnings Call Insights: First Industrial Realty Trust (FR) Q1 2026 Management view "We delivered some significant development leasing wins and signed a key renewal in Southern California for our largest remaining 2026 expiration" (President, CEO & Director Peter Baccile). "We're also capturing significant value creation via a pending $131 million land sale" and "we expect this transaction to close...
Earnings Call Insights: First Industrial Realty Trust (FR) Q1 2026 Management view "We delivered some significant development leasing wins and signed a key renewal in Southern California for our largest remaining 2026 expiration" (President, CEO & Director Peter Baccile). "We're also capturing significant value creation via a pending $131 million land sale" and "we expect this transaction to close in June" (President Baccile). "In our portfolio, overall touring activity has increased for our availabilities with decision-making accelerating for space sizes under 200,000 square feet within our development portfolio" (President Baccile). "Our in-service occupancy at quarter end was 94.3%, in line with our expectations" and "we've now taken care of 61%" of 2026 rollovers "by square footage" with an "overall cash rental rate increase for new and renewal leasing" of "41%" (President Baccile). "First quarter 2026 NAREIT funds from operations were $0.68 per fully diluted share" and "the first quarter 2026 FFO per share was negatively impacted by $0.04 per share of advisory costs related to the contested proxy campaign that was initiated by Land & Buildings" (CFO Scott Musil). "Our cash same-store NOI growth for the quarter, excluding termination fees, was 8.7%" (CFO Musil). Outlook "Our guidance range for NAREIT FFO is now $3.05 to $3.15 per share" and "2026 FFO guidance range, absent these advisory costs is $3.09 to $3.19 per share, which is unchanged compared to our last call" (CFO Musil). "Average quarter-end in-service occupancy" is guided to "94% to 95%" and "cash same-store NOI growth before termination fees" is guided to "5% to 6%" (CFO Musil). "This range now reflects approximately 1.3 million square feet of incremental development leasing and the 708,000 square footer in Central Pennsylvania, all to occur in the second half of the year" (CFO Musil). "Our G&A expense guidance range is $42 million to $43 million which excludes the $5.6 million of incremental advisory...
Earnings Call Insights: Altisource Portfolio Solutions S.A. (ASPS) Q1 2026 Management View "We are off to a strong start this year" (Chairman & CEO William Shepro), adding, "For the quarter, we grew service revenue and pretax GAAP earnings compared to the first quarter of 2025 from sales wins and lower debt-related interest and transaction costs." "For the first quarter, we generated service reven...
Earnings Call Insights: Altisource Portfolio Solutions S.A. (ASPS) Q1 2026 Management View "We are off to a strong start this year" (Chairman & CEO William Shepro), adding, "For the quarter, we grew service revenue and pretax GAAP earnings compared to the first quarter of 2025 from sales wins and lower debt-related interest and transaction costs." "For the first quarter, we generated service revenue of $45.1 million, a 10% increase over the first quarter of 2025" (Chairman & CEO Shepro). He attributed the mix to "71% growth in service revenue in our Origination segment" alongside "a 5% revenue decline in our Servicer and Real Estate segment" driven by "a onetime 2025 pricing adjustment benefit in our foreclosure trustee business." "The Servicer and Real Estate segment is positioned extremely well with Hubzu inventory at 17,200 homes as of the end of the first quarter" (Chairman & CEO Shepro), and he later updated that "Hubzu inventory is standing at roughly 18,800 assets as of earlier this week." "The company generated first quarter pretax GAAP income of $400,000 compared to a $4.5 million loss in the first quarter of 2025" (Chairman & CEO Shepro), and said the change was "primarily attributable to lower interest expense and debt exchange transaction expenses incurred last year." "Net cash provided by operating activities was $4.5 million" (Chairman & CEO Shepro), and he added, "We ended the quarter with $30.3 million in unrestricted cash." "First quarter 2026 service revenue of $31.4 million decreased 5%" in Servicer and Real Estate, and "adjusted EBITDA of $10.8 million decreased by 10%" (Chairman & CEO Shepro), which he tied to the foreclosure trustee pricing adjustment and "lower volume in our renovation business." "For the quarter, we won an estimated $12.4 million in annualized stabilized service revenue wins" (Chairman & CEO Shepro), noting, "Two of the larger first quarter wins were in our higher margin foreclosure trustee and title businesses." "First quart...
Earnings Call Insights: Selective Insurance Group (SIGI) Q1 2026 Management view “We delivered a solid start to the year, demonstrating the strength and consistency of our operating model in an increasingly competitive market,” John J. Marchioni said, adding, “Our reserves remain stable across all insurance segments and lines of business, and our underlying profitability reinforces our confidence ...
Earnings Call Insights: Selective Insurance Group (SIGI) Q1 2026 Management view “We delivered a solid start to the year, demonstrating the strength and consistency of our operating model in an increasingly competitive market,” John J. Marchioni said, adding, “Our reserves remain stable across all insurance segments and lines of business, and our underlying profitability reinforces our confidence in achieving our full year guidance.” Marchioni emphasized underwriting discipline over growth: “We continue to prioritize underwriting margins over top-line growth,” and said Selective’s “pricing posture on commercial casualty in both standard commercial and excess and surplus lines fully reflects our view on current loss trends.” On growth/mix, Marchioni said “premiums declined 1% year-over-year with E&S up 1% and Standard Commercial Lines down 1%,” and added, “In Standard Personal Lines, premiums declined 6%, while our target mass affluent market business grew by 1%.” He also said, “Our relative exposure to contractors has declined within our new business mix.” On AI investments, Marchioni said “a significant portion of our strategic technology investments in 2026 is focused on improving risk selection, pricing accuracy and productivity,” citing that an “AI claims ingestion tool has processed more than 0.5 million documents” and that contractual-risk-transfer automation returns “over 90% of results… within 2 minutes.” “For the quarter, we reported fully diluted EPS of $1.58 and non-GAAP operating EPS of $1.69,” Patrick Brennan said, adding, “Our GAAP combined ratio was 98.3%, including 6.2 points of catastrophe losses.” Outlook “We are reaffirming the guidance we communicated in January,” Brennan said. “For 2026, we expect to see a GAAP combined ratio between 96.5% and 97.5%, assuming 6 points of catastrophe losses,” Brennan said, adding, “we expect our full year underlying combined ratio to fall within our original 90.5% to 91.5% range.” On investment income, Brennan sa...